@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-MHGCKFJ8-S
  skos:prefLabel "Antibiotiques antinéoplasiques"@fr, "Antibiotics, Antineoplastic"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-MSF3P3V1-C
  skos:prefLabel "Inhibiteurs de la topoisomérase-II"@fr, "Topoisomerase II Inhibitors"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-QNQ2JMZG-H
  skos:prefLabel "Daunorubicin"@en, "Daunorubicine"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-TJWRD1F9-9 .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJWRD1F9-9
  mesh:allowableQualifier jvr:-G4R176S9-J, jvr:-CB30NGKB-3, jvr:-NHL3D2X0-S, jvr:-Q3979798-W, jvr:-THHNVC7V-3, jvr:-NB0XHT3S-N, jvr:-FWD2BGQ0-9, jvr:-L6C0XPHT-4, jvr:-H7K65Q8S-Z, jvr:-T9HQD7ST-J, jvr:-XV06LPML-W, jvr:-G30ZJ446-J, jvr:-S0CS1X5R-5, jvr:-M63HSDM7-1, jvr:-D0F21513-5, jvr:-W6SQV79N-S, jvr:-TJHVZCRZ-0, jvr:-SBNWSM1T-R, jvr:-R0ZCQ8X6-J, jvr:-NFTHND7Q-8, jvr:-BT300B3G-Q, jvr:-WK5F724J-1, jvr:-HQRFT0C6-B, jvr:-NKM836P1-M, jvr:-R3QWLHRG-V ;
  skos:hiddenLabel "NSC-256439"@fr, "NSC-256439"@en, "NSC256439"@fr, "IMI-30"@fr, "IMI-30"@en, "Chlorhydrate d'idarubicine"@fr, "Idarubicin Hydrochloride"@en, "IMI30"@fr ;
  dc:created "1988-05-17"^^xsd:date ;
  skos:definition "An orally administered anthracycline antineoplastic. The compound has shown activity against BREAST NEOPLASMS; LYMPHOMA; and LEUKEMIA."@en ;
  skos:inScheme jvr: ;
  skos:altLabel "ZRP63D75JW"@fr, "ZRP63D75JW"@en, "5VV3MDU5IE"@fr, "5VV3MDU5IE"@en, "4-Desmethoxydaunorubicin"@en, "57852-57-0 (Idarubicin Hydrochloride)"@fr, "57852-57-0 (Idarubicin Hydrochloride)"@en, "58957-92-9 (Idarubicin)"@fr, "58957-92-9 (Idarubicin)"@en, "4-Demethoxydaunorubicin"@en, "5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)-"@en, "5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)-"@fr ;
  dc:established "1989-01-01"^^xsd:date ;
  a skos:Concept, mesh:Descriptor ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D015255> ;
  skos:prefLabel "Idarubicin"@en, "Idarubicine"@fr ;
  mesh:pharmacologicalAction jvr:-MHGCKFJ8-S, jvr:-MSF3P3V1-C ;
  skos:broader jvr:-QNQ2JMZG-H ;
  dc:modified "2013-07-08"^^xsd:date .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .